Suppression of human monocyte tissue factor synthesis by antisense oligodeoxynucleotide

被引:17
|
作者
Stephens, AC
Rivers, RPA
机构
[1] Department of Paediatrics, Imp. Coll. Sch. of Med. at St. M., Paddington
关键词
tissue factor; antisense oligodeoxynucleotide; endocytosis; monocyte; CD14;
D O I
10.1016/S0049-3848(97)00027-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tissue factor (TF) is a cellular receptor and cofactor for factor V11/V11a which initiates the blood coagulation cascade. An understanding of TF cell biology is therefore of critical importance to the pathophysiology of many disorders. We have utilized an antisense oligodeoxynucleotide (aODN), directed against human blood monocyte TF mRNA, to investigate the feasibility of inhibiting the synthesis of TF. CD14 receptor-mediated endocytosis was used as a means of delivering TF aODN to monocytes. This DNA carrier system consists of the fab portion of anti-CD14 antibody covalently linked to poly(L-lysine). Go-treatment of monocytes with TF aODN and endotoxin resulted in 80.4+/-2.2% suppression of TF activity when compared with control endotoxin stimulated cells. Control experiments with TF sense ODN, mismatched aODN, and an irrelevant aODN were performed to exclude nonspecific inhibitory effects. The cytotoxicity of the DNA carrier complex was also evaluated. These results demonstrate that this TF mRNA antisense ODN specifically suppressed the synthesis of biologically active monocyte TF and that antisense ODNs might therefore represent a useful tool in the investigation of monocyte/macrophage TF function. (C) 1997 Elsevier Science Ltd.
引用
收藏
页码:387 / 398
页数:12
相关论文
共 50 条
  • [31] Suppression of tumor necrosis factor A synthesis in human mononuclear cells via shock wave-delivered antisense oligonucleotides
    Tschöp, K
    Hartmann, G
    Thompson, S
    Erhardt, S
    Delius, M
    Endres, S
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 494 - 494
  • [32] HELIX-STABILIZING AGENT, CC-1065, ENHANCES SUPPRESSION OF TRANSLATION BY AN ANTISENSE OLIGODEOXYNUCLEOTIDE
    KIM, DY
    SWENSON, DH
    CHO, DY
    TAYLOR, HW
    SHIH, DS
    ANTISENSE RESEARCH AND DEVELOPMENT, 1995, 5 (02): : 149 - 154
  • [33] Human monocyte subsets differentially express tissue factor in vivo and in vitro
    Thaler, B.
    Krychtiuk, K. A.
    Hohensinner, P. J.
    Lenz, M.
    Huber, K.
    Heinz, G.
    Wojta, J.
    Speidl, W.
    CARDIOVASCULAR RESEARCH, 2018, 114 : S133 - S133
  • [34] Adenosine inhibits LPS-induced tissue factor by human monocyte
    Broussas, M
    Lefebvre-Cornillet, P
    Potron, G
    Nguyen, P
    THROMBOSIS AND HAEMOSTASIS, 1999, : 461 - 461
  • [35] Differentiation intensifies the susceptibility of pheochromocytoma cells to antisense oligodeoxynucleotide-dependent suppression of acetylcholinesterase activity
    Grifman, M
    Soreq, H
    ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 1997, 7 (04): : 351 - 359
  • [36] Tissue factor expression and monocyte infiltration in human crescentic glomerulonephritis (CGN).
    Grandaliano, G
    Monno, R
    Ranieri, E
    Brunaccini, A
    Gesualdo, L
    Schena, FP
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A2269 - A2269
  • [37] Co-expression of factor V, tissue factor and tissue factor pathway inhibitor mRNAs by human monocyte, monocytic cell lines and monocyte-derived cells
    Nguyen, P
    Cornillet-Lefèbvre, P
    Broussas, M
    Potron, G
    THROMBOSIS AND HAEMOSTASIS, 1999, : 460 - 460
  • [38] PHARMACOKINETICS, TISSUE DISTRIBUTION, AND STABILITY OF ANTISENSE OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE ISIS-3466 IN MICE
    SAIJO, Y
    PERLAKY, L
    WANG, HM
    BUSCH, H
    ONCOLOGY RESEARCH, 1994, 6 (06) : 243 - 249
  • [39] A C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDE INHIBITS NORMAL HUMAN HEMATOPOIESIS INVITRO
    GEWIRTZ, AM
    CALABRETTA, B
    SCIENCE, 1988, 242 (4883) : 1303 - 1306
  • [40] Effect of antisense oligodeoxynucleotide targeting survivin on growth of human gastric cancer cells
    Xu, Lantao
    BANGLADESH JOURNAL OF PHARMACOLOGY, 2013, 8 (01) : 73 - 77